KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcosa (ACA) EBITDA (2017 - 2025)

Arcosa (ACA) has disclosed EBITDA for 9 consecutive years, with $79.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 82.87% to $79.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $341.9 million through Dec 2025, up 73.03% year-over-year, with the annual reading at $341.9 million for FY2025, 73.03% up from the prior year.
  • EBITDA hit $79.0 million in Q4 2025 for Arcosa, down from $112.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $208.1 million in Q4 2022 to a low of $15.6 million in Q4 2021.
  • Historically, EBITDA has averaged $60.7 million across 5 years, with a median of $50.0 million in 2022.
  • Biggest five-year swings in EBITDA: soared 1233.97% in 2022 and later crashed 79.43% in 2023.
  • Year by year, EBITDA stood at $15.6 million in 2021, then skyrocketed by 1233.97% to $208.1 million in 2022, then crashed by 79.43% to $42.8 million in 2023, then grew by 0.93% to $43.2 million in 2024, then soared by 82.87% to $79.0 million in 2025.
  • Business Quant data shows EBITDA for ACA at $79.0 million in Q4 2025, $112.3 million in Q3 2025, and $94.8 million in Q2 2025.